Hepatotoxicity associated with the dietary supplement OxyELITE Pro™ - Hawaii, 2013

Drug Testing and Analysis

Volumn 8, Issue 3-4, 2016, Pages 319-327

  Johnston, David I ^a   Chang, Arthur ^b   Viray, Melissa ^a   Chatham Stephens, Kevin ^b   He, Hua ^a   Taylor, Ethel ^b   Wong, Linda L ^c   Schier, Joshua ^b   Martin, Colleen ^b   Fabricant, Daniel ^d   Salter, Monique ^e   Lewis, Lauren ^b   Park, Sarah Y ^a  

^a HAWAII STATE DEPARTMENT OF HEALTH   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^c QUEEN S MEDICAL CENTER   (United States)

^d Natural Products Association   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Dietary supplements; Toxic hepatitis

Indexed keywords

DISEASES; FOOD ADDITIVES; NUTRITION; VITAMINS;

CHEMICAL ANALYSE; DEPARTMENT OF HEALTHS; FULMINANT HEPATIC FAILURES; HEALTH BENEFITS; HEPATOTOXICITY; LIVER TRANSPLANTATION; MEDICAL RECORD; TOXIC HEPATITIS; TRACEBACK; WEIGHT LOSS;

DIETARY SUPPLEMENTS;

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; PLANT MEDICINAL PRODUCT;

ABDOMINAL PAIN; ACUTE HEPATITIS; ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ANOREXIA; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DIZZINESS; DRUG EXPOSURE; EPIDEMIC; FATIGUE; FEMALE; FEVER; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; LENGTH OF STAY; LIQUID CHROMATOGRAPHY; LIVER INJURY; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; MASS SPECTROMETRY; MEDICAL RECORD REVIEW; NAUSEA; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SKIN DISCOLORATION; UNITED STATES; VOMITING; WEIGHT REDUCTION; ADVERSE EFFECTS; CASE REPORT; CHEMICAL AND DRUG INDUCED LIVER INJURY; CHEMICALLY INDUCED; DIETARY SUPPLEMENT; HAWAII; HEPATITIS; LIVER FAILURE; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHEMICAL AND DRUG INDUCED LIVER INJURY; DIETARY SUPPLEMENTS; FEMALE; HAWAII; HEPATITIS; HUMANS; LIVER FAILURE; MALE; MIDDLE AGED; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84949255528     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1894     Document Type: Article

References (39)

1. R. L. Bailey, J. J. Gahche, P. E. Miller, P. R. Thomas, J. T. Dwyer . Why US adults use dietary supplements. JAMA Intern. Med. 2013, 173, 355.
2. V. J. Navarro . Herbal and dietary supplement hepatotoxicity. Semin. Liver Dis. 2009, 29, 373.
3. H. M. Blanck, M. K. Serdula, C. Gillespie, D. A. Galuska, P. A. Sharpe, J. M. Conway, L. K. Khan, B. E. Ainsworth . Use of nonprescription dietary supplements for weight loss is common among Americans. J. Am. Diet. Assoc. 2007, 107, 441.
4. A. Reuben, D. G. Koch, W. M. Lee . Drug-induced acute liver failure: results of a US multicenter, prospective study. Hepatology. 2010, 52, 2065.
5. F. Stickel, E. Patsenker, D. Schuppan . Herbal hepatotoxicity. J. Hepatol. 2005, 43, 901.
6. J. D. Estes, D. Stolpman, A. Olyaei, C. L. Corless, J. M. Ham, J. M. Schwartz, S. L. Orloff . High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch. Surg. 2003, 138, 852.
7. M. W. Russo, J. A. Galanko, R. Shrestha, M. W. Fried, P. Watkins . Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl. 2004, 10, 1018.
8. M. M. Roytman, P. Porzgen, C. L. Lee, L. Huddleston, T. T. Kuo, P. Bryant-Greenwood, L. L. Wong, N. Tsai . Outbreak of severe hepatitis linked to weight-loss supplement OxyELITE Pro. Am. J. Gastroenterol. 2014, 109, 1296.
9. Notes from the field: acute hepatitis and liver failure following the use of a dietary supplement intended for weight loss or muscle building--May-October 2013. MMWR Morb. Mortal. Wkly. Rep. 2013, 62, 817.
10. Hawaii Department of Health. Department of Health Investigates Hepatitis, Liver Failure in Persons Taking Diet Supplements. Available at: http://health.hawaii.gov/news/files/2013/05/13-055-Department-of-Health-Investigates-Hepatitis-Liver-Failure-in-Persons-Taking-Diet-Suppliments.pdf [13 December 2013].
11. Haw. Rev. Stat. § 321-29(b) Available at: http://www.capitol.hawaii.gov/hrscurrent/Vol06_Ch0321-0344/HRS0321/HRS_0321-0029.htm [1 February 2015].
12. R. Teschke, C. Frenzel, J. Schulze, A. Eickhoff . Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods. World J. Gastroenterol. 2013, 19, 2864.
13. R. Teschke, A. Schwarzenboeck, A. Eickhoff, C. Frenzel, A. Wolff, J. Schulze . Clinical and causality assessment in herbal hepatotoxicity. Expert Opin. Drug Saf. 2013, 12, 339.
14. R. Teschke, A. Wolff, C. Frenzel, J. Schulze, A. Eickhoff . Herbal hepatotoxicity: a tabular compilation of reported cases. Liver Int. 2012, 32, 1543.
15. C. Bunchorntavakul, K. R. Reddy . Review article: herbal and dietary supplement hepatotoxicity. Aliment. Pharmacol. Ther. 2013, 37, 3.
16. Haw. Rev. Stat. § 328-25(a)(3) Available at: http://www.capitol.hawaii.gov/hrscurrent/Vol06_Ch0321-0344/HRS0328/HRS_0328-0025.htm [1 February 2015].
17. T. Kanda, O. Yokosuka, M. Tada, T. Kurihara, S. Yoshida, Y. Suzuki, K. Nagao, H. Saisho . N-nitroso-fenfluramine hepatotoxicity resembling chronic hepatitis. J. Gastroenterol. Hepatol. 2003, 18, 999.
18. Food and Drug Administration. USP Labs, LLC 4/24/12, Warning Letter. Available at: http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2012/ucm302167.htm [16 January 2013].
19. Hawaii Department of Health. Department of Health Requests Voluntary Removal of OxyElite Pro Supplement from Sale. Available at: http://health.hawaii.gov/news/files/2013/05/13-056-DOH-Requests-Voluntary-Removal-of-OxyElite-Pro-From-Sale1.pdf [13 December 2013].
20. Hawaii Department of Health. Dietary Supplements: Be an Informed Consumer. Available at: http://health.hawaii.gov/docd/files/2013/04/Dietary-Supplements-Factsheet.pdf [19 December 2013].
21. Hawaii Department of Health. Voluntary Destruction of Embargoed OxyElite Pro Products. Available at: http://health.hawaii.gov/news/files/2013/05/13-066-Vountary-Destruction-of-Embargoed-OxyELITE-Pro-Products.pdf [13 December 2013].
22. Food and Drug Administration. FDA News Release: USPlabs LLC recalls OxyElite Pro dietary supplements; products linked to liver illnesses. Available at: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm374395.htm [13 December 2013].
23. M. Adachi, H. Saito, H. Kobayashi, Y. Horie, S. Kato, M. Yoshioka, H. Ishii . Hepatic injury in 12 patients taking the herbal weight loss AIDS Chaso or Onshido. Ann. Intern. Med. 2003, 139, 488.
24. K. Kawata, Y. Takehira, Y. Kobayashi, M. Kitagawa, M. Yamada, K. Hanajima, G. Murohisa, M. Kawamura, Y. Iwaoka, T. Wada, S. Morita, M. Iwaizumi, S. Makino . Three cases of liver injury caused by Sennomotokounou, a Chinese dietary supplement for weight loss. Intern. Med. 2003, 42, 1188.
25. E. Elinav, G. Pinsker, R. Safadi, O. Pappo, M. Bromberg, E. Anis, L. Keinan-Boker, E. Broide, Z. Ackerman, D. N. Kaluski, B. Lev, D. Shouval . Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. J. Hepatol. 2007, 47, 514.
26. A. M. Schoepfer, A. Engel, K. Fattinger, U. A. Marbet, D. Criblez, J. Reichen, A. Zimmermann, C. M. Oneta . Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J. Hepatol. 2007, 47, 521.
27. T. L. Fong, K. C. Klontz, A. Canas-Coto, S. J. Casper, F. A. Durazo, T. J. Davern II, P. Hayashi, W. M. Lee, L. B. Seeff . Hepatotoxicity due to hydroxycut: a case series. Am. J. Gastroenterol. 2010, 105, 1561.
28. Food and Drug Administration. Warning Letter: USP Labs 10/11/13. Available at: http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2013/ucm371203.htm [11 November 2013].
29. J. T. Favreau, M. L. Ryu, G. Braunstein, G. Orshansky, S. S. Park, G. L. Coody, L. A. Love, T. L. Fong . Severe hepatotoxicity associated with the dietary supplement LipoKinetix. Ann. Intern. Med. 2002, 136, 590.
30. Food and Drug Administration. Reporting Serious Problems to FDA. Available at: http://www.fda.gov/Safety/MedWatch/HowToReport/default.htm [17 November 2013].
31. K. C. Klontz, H. J. DeBeck, P. LeBlanc, K. M. Mogen, B. J. Wolpert, J. L. Sabo, M. Salter, S. L. Seelman, E. L. Elliot, S. E. Lance, D. S. Steigman, K. Gensheimer . The Role of Adverse Event Reporting in a U.S. Food and Drug Administration Response to a Multi-State Outbreak of Liver Disease Associated with a Dietary Supplement. Public Health Rep. in press.
32. Queensland Health--Queensland Government. Sport and dietary supplement warning. Available at: http://www.health.qld.gov.au/news/stories/131122-sports-dietary.asp [13 December 2013].
33. New Zealand Ministry for Primary Industries. Director-General Statement under the Food Act 1981. Available at: http://www.mpi.govt.nz/portals/0/Documents/food/dg-statement-oxyelite.pdf [13 December 2013].
34. M. K. Muth, M. J. Ball, M. C. Coglaiti, S. A. Karns . Model to estimate costs of using labeling as a risk reduction strategy for consumer products regulated by the Food and Drug Administration: Prepared for U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, RTI International, Research Triangle Park, NC, 2011.
35. V. J. Navarro, H. Barnhart, H. L. Bonkovsky, T. Davern, R. J. Fontana, L. Grant, K. R. Reddy, L. B. Seeff, J. Serrano, A. H. Sherker, A. Stolz, J. Talwalkar, M. Vega, R. Vuppalanchi . Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 2014, 60, 1399.
36. J. D. Lewis, B. L. Strom . Balancing safety of dietary supplements with the free market. Ann. Intern. Med. 2002, 136, 616.
37. Food and Drug Administration. Dietary Supplements. Available at: http://www.fda.gov/food/dietarysupplements/ [11 November 2013].
38. Food and Drug Administration. Dietary Supplement and Nonprescription Drug Consumer Protection Act. Available at: http://www.fda.gov/regulatoryinformation/legislation/federalfooddrugandcosmeticactfdcact/significantamendmentstothefdcact/ucm148035.htm [11 November 2013].
39. J. Kennedy . Herb and supplement use in the US adult population. Clin. Ther. 2005, 27, 1847.